Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | CHKA | P35790 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL27350264 | 0.78 | PLD1 (0.42) | TDP1TSHRNAPRTCHRNB2CHRNA4 | |
| Pyridine SCHEMBL28177478 | 0.78 | TSHR (0.41) | TDP1TSHRNAPRT | |
| Pyridine SCHEMBL25338956 | 0.76 | TSHR (0.50) | TDP1TSHRNAPRTCHKACHRNB2 | |
| N-Methyl Pyrrolidine (Nmp) SCHEMBL15264514 | 0.74 | TDP1 (0.47) | TDP1TSHRNAPRTCHKACHRNB2 | |
| Pyridine SCHEMBL28167952 | 0.74 | TDP1 (0.47) | TDP1TSHRNAPRTCHKACHRNB2 | |
| Pyridine SCHEMBL6952793 | 0.73 | TSHR (0.75) | TDP1TSHRNAPRT | |
| Cyclooctane SCHEMBL9180329 | 0.73 | TSHR (0.75) | TDP1TSHRNAPRT | |
| Pyridine SCHEMBL6114733 | 0.73 | TSHR (0.75) | TDP1TSHRNAPRT | |
| Cyclohexane SCHEMBL1898523 | 0.73 | TSHR (0.75) | TDP1TSHRNAPRT | |
| Pyridine SCHEMBL4938377 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103124736-B | Functionalized fluoroalkyl fluorophosphate salts | MERCK PATENT GMBH (DE) | 2016-05-11 | — | — | CN | disclosed |